文献速递腹部MR

MRI衍生细胞外容积评估代谢相关脂肪性肝病患者肝纤维化

MRI-derived extracellular volume to assess liver fibrosis in patients with metabolic-associated steatotic liver disease.
PubMed 文献 · Abdom Radiol (NY) · 2025-04-17

单中心横断面研究前瞻性纳入54例MASLD患者,比较MRI T1 mapping与细胞外容积(ECV)对MRE所评肝纤维化的鉴别能力。显著纤维化(F2-F4)组天然T1(954±126 vs. 820±123)与ECV(37.9% vs. 29.1%)均高于无/轻度纤维化组,鉴别AUC分别为0.85和0.84。作者认为天然T1与ECV有潜力作为MASLD纤维化无创分期的替代方法,但需更大队列进一步验证。

要点

  • 显著纤维化(F2-F4)患者天然T1为954±126、ECV为37.9%,均高于无/轻度纤维化组(820±123、29.1%)。
  • 天然T1与ECV鉴别MRE所评显著纤维化的AUC分别为0.85和0.84。
  • 肝硬度与天然T1(r=0.512)及ECV(r=0.443)均相关。

核心结论

  • 天然T1与ECV有潜力作为MASLD患者纤维化无创分期的替代方法,但需在更大队列中进一步验证。

研究设计与样本

  • 单中心横断面研究,前瞻性纳入54例MASLD患者,行MRI肝脏T1 mapping并计算ECV,以MR弹性成像(MRE)评估的肝硬度为参考分组。

诊断标准与关键数值

  • 以MRE所评显著纤维化(F2-F4)为参照,天然T1的AUC=0.85、ECV的AUC=0.84;显著纤维化组天然T1 954±126 vs. 无/轻度纤维化组820±123(p<0.001),ECV 37.9% vs. 29.1%(p<0.001)。

临床应用与阅片要点

  • 作者认为天然T1与ECV有潜力作为MASLD肝纤维化无创分期的替代方法,但需在更大队列中进一步验证。

局限性

  • 作者指出需在更大队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Metabolic associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease, and non-invasive fibrosis staging still represents a challenge. Our main objective was to estimate the degree of liver fibrosis in these patients using T1 mapping and the extracellular volume (ECV) by MRI in comparison with liver stiffness assessed by MR elastography (MRE).

METHODS: In a single-center cross-sectional study, patients with MASLD were prospectively enrolled and underwent MRI with liver T1 mapping and ECV calculations. Groups with and without significant liver fibrosis assessed by MRE were compared with the Mann-Whitney test, chi-square test, and Fisher's exact test. Correlation analysis was conducted using Spearman's test, and a receiver operating characteristic (ROC) curve was generated to assess the ability of ECV to differentiate between groups.

RESULTS: This study evaluated 54 patients, 37% were men, with a mean age of 58.0 ± 12.0 years. Mild liver fibrosis (F0-F1) was present in 38 patients, and significant fibrosis (F2-F4) was detected in 16 patients. Patients with significant fibrosis presented higher native T1 (954 ± 126 vs. 820 ± 123; p < 0.001) and ECV (37.9% vs. 29.1%; p < 0.001) values than those with no/mild fibrosis. Liver stiffness was correlated with native T1 (r = 0.512, p < 0.001) and ECV (r = 0.443, p < 0.001). The native liver T1 and ECV differentiated patients with and without significant liver fibrosis on MRE (AUC = 0.85 and 0.84, respectively).

CONCLUSION: Native T1 and ECV show potential as an alternative method for the non-invasive staging of fibrosis in patients with MASLD, although further validation in larger cohorts is needed.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. de Oliveira Terzi FV, Parente DB, Camargo GC, et al. MRI-derived extracellular volume to assess liver fibrosis in patients with metabolic-associated steatotic liver disease. Abdom Radiol (NY). 2025. PMID: 40246797. doi:10.1007/s00261-025-04945-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。